Trials / Completed
CompletedNCT02261298
ONO-4538 Phase I Study in Patients With Solid Tumor
ONO-4538 Multicenter, Open-label, Uncontrolled, Phase I Multiple Dose Study in Solid Tumor
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to investigate the safety, pharmacokinetics, pharmacology and efficacy of ONO-4538 administered to Korean patients with advanced or recurrent solid tumors who are refractory or intolerant to standard therapy or for whom no appropriate treatment is available.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-4538 |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-06-01
- Completion
- 2020-04-01
- First posted
- 2014-10-10
- Last updated
- 2024-05-03
Locations
5 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02261298. Inclusion in this directory is not an endorsement.